Why Moderna Stock Surged Today
Published
With a competitor stumbling, the biotech could see increased demand for its COVID-19 vaccine.
Full ArticlePublished
With a competitor stumbling, the biotech could see increased demand for its COVID-19 vaccine.
Full ArticleThe coronavirus vaccine maker could supply as many as 1 billion doses in 2021.